Resource Center
Emmes possesses deep experience in clinical research which we leverage on behalf of our clients. It is through our collaborative efforts with you that Emmes has conducted over 2,150 clinical trials and published 2,300+ peer-reviewed articles.
In this section of our site, we share our experience and publications with you as a tribute to our ongoing collaboration.
Resources
Publications
Cytokine profiles in seronegative volunteers immunized with a recombinant canarypox and gp120 prime-boost HIV-1 vaccine. NIAID AIDS Vaccine Evaluation Group
2000
Sabbaj, S., Mulligan, M.J., Hsieh, R.H., Belshe, R.B., ,
Diminution of the Anti-PRP response to a combined DtaP/Hib vaccine by concurrent inactivated poliovirus vaccination
2000
Rennels, M., Englund, J.A., Bernstein, D.I., Losonsky, G.A., Anderson, E.L., Pichichero, M.E., Munoz, F.M., Wolff, M.C.
Double bonus or double trouble? Recruitment of married couples in the Age-Related Eye-Disease Study (AREDS)
2000
Gensler, G.R., Group, A.R.E.D.S.Research
Early immune reconstitution after potent antiretroviral therapy in HIV-infected children correlates with the increase in thymus volume
2000
Vigano, A., Vella, S., Saresella, M., Vanzulli, A., Bricalli, D., Di Fabio, S., Ferrante, P., Andreotti, M., Pirillo, M., Dally, L.G., Clerici, M., Principi, N.
EBV disease and lymphoproliferative disease (LPD) after a first liver transplant in children enrolled in the SPLIT registry
2000
McDiarmid, S.V., Anand, R., Group, theS.P.L.I.T.Rese
Emerging immunosuppressive profile of pediatric renal transplant recipients and its impact on graft survival
2000
Elshihabi, I., Stablein, D.M., Tejani, A.
Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control
2000
Longini, I.M., Halloran, M.E., Nizam, A., Wolff, M.C., Mendelman, P.M., Fast, P.E., Belshe, R.B.
For the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS): Impact of puberty on renal function in children with chronic renal insufficiency (CRI)
2000
Schurman, S., Stablein, D.M., Garin, E.H., Tejani, A.
Immunization with recombinant canarypox vectors expressing membrane-anchored glycoprotein 120 followed by glycoprotein 160 boosting fails to generate antibodies that neutralize R5 primary isolates of human immunodeficiency virus Type 1
2000
Bures, R., Gaitan, A., Zhu, T., Graziosi, C., McGrath, K.M., Tartaglia, J., Caudrelier, P., Habib, E., Klein, M., Lazzarin, A., Stablein, D.M., Deers, M., Corey, L., Greenberg, M.L., Schwartz, D.H., Montefiore, D.C.